Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government

Office of Research & Development

print icon sign up for VA Research updates

VA SHIELD (Central Biospecimen and Data Repository)

A comprehensive repository of disease biospecimens and associated data relating to COVID-19 and other emerging diseases.

Vision Statement:   Advance understanding of disease and further diagnostic, therapeutic, and prevention strategies for immediate deployment in clinical environments.

Purpose:   Create a comprehensive infectious disease repository of specimens and associated data available to advance research, improve diagnostic and therapeutic capabilities, and develop strategies for immediate deployment in VA’s clinical environments.

Background

Request for Coordinating Center Applications

VA SHIELD is expanding its activities and is seeking applications for a Coordinating Center. See RFA for details. Deadline for all application submissions is July 31, 2021.

VA Science and Health Initiative to Combat Infectious and Life-Threatening Diseases (VA SHIELD) is a comprehensive, secure biorepository of specimens and associated data related to COVID-19 and other emerging diseases. These specimens and data are available to authorized VA investigators—and, under certain circumstances, to their external collaborators—to advance scientific understanding in support of developing diagnostic, therapeutic, and preventative strategies for use in clinical care. 

The COVID-19 pandemic has highlighted opportunities for VA to rapidly respond to emerging diseases in a coordinated manner.

VA has a major role to play in the national response to COVID-19.  Veterans who use VA care represent a vulnerable population in the United States. Their median age is 65 years, nearly a third are racial or ethnic minorities, and many have one or more chronic diseases. These factors overlap with risk of severe COVID-19 and other emerging infectious diseases. 

COVID-19 is the most recent instance of a virus rapidly spreading across the United States.  Its devastating impact had highlighted the importance of establishing a biobank biospecimen and data repository to support a proactive response to both current and future pandemics.

VA SHIELD supports VA’s fourth mission: to improve the nation’s preparedness for national emergencies and to support emergency management, public health, safety, and homeland security efforts.  As the largest integrated healthcare provider in the country and through its geographic breadth and size, VA is uniquely positioned to play a critical role in accelerating research efforts for future outbreaks. Through the establishment and implementation of the biorepository, VA is well-positioned to respond rapidly to national and international biological events and to substantially contribute to clinical research and development.

Team members at the Atlanta VAMC biorepository site. <em>(Photo by Adam Hernandez)</em> Team members at the Atlanta VAMC biorepository site. (Photo by Adam Hernandez)
A shipment of serum specimens—the first specimens to be added to the SHIELD biobank—is received in March 2021 by a team at the Cincinnati VA that is part of the biobank network. A shipment of serum specimens—the first specimens to be added to the SHIELD biobank—is received in March 2021 by a team at the Cincinnati VA that is part of the biobank network.


Questions about the R&D website? Email the Web Team.

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.